Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| PDPagerDuty, Inc. | $1.08B | 6.9× | $492.55M | +5.4% | $173.37M | $233.65M | $412.82M | Fair valued |
| QNSTQuinstreet, Inc | $1.08B | 13.5× | $1.29B | +18.3% | $81.24M | $128.32M | $77.66M | Undervalued |
| CRAICra International, Inc. | $1.08B | 22.9× | $751.58M | +9.3% | $54.78M | $21.44M | $84.65M | Fair valued |
| IRMDIradimed Corp | $1.08B | 47.1× | $83.81M | +14.4% | $22.48M | $59.08M | $59.22K | Overvalued |
| SAFESafehold Inc. | $1.08B | 9.4× | $385.55M | +5.4% | $114.47M | $15.92M | $4.66B | Undervalued |
| LACLithium Americas Corp. | $1.08B | — | — | — | — | $822.78M | $21.2M | Fair valued |
| OIO-I Glass, Inc. | $1.09B | — | $6.43B | -1.6% | -$129M | $339M | $4.99B | Fair valued |
| CRMLCritical Metals Corp. | $1.09B | — | — | — | — | $80.92M | $20.29K | Fair valued |
| ELVRElevra Lithium Ltd | $1.09B | 15.7× | A$223.37M | +11.2% | -A$381.74M | A$72.29M | A$80.22M | Fair valued |
| SVRASavara Inc | $1.1B | — | $257K | — | -$49.62M | $41.8M | $31.2M | Fair valued |
| TRIPTripAdvisor, Inc. | $1.1B | 928.2× | $1.89B | +3.1% | $40M | $843.2M | $893.9M | Undervalued |
| MSEXMiddlesex Water Co | $1.1B | 22.6× | $194.69M | +1.5% | $42.82M | $1.8M | $404.75M | Fair valued |
| UPWKUpwork, Inc | $1.1B | 11.5× | $787.78M | +2.4% | $115.43M | $476.04M | $379.41M | Undervalued |
| DLXDeluxe Corp | $1.1B | 11.0× | $2.13B | +0.5% | $82.1M | $34.9M | $1.47B | Undervalued |
| LARLithium Argentina AG | $1.1B | — | $4.84M | +12.9% | -$28.27M | $61.13M | $2.61M | Fair valued |
| SLDBSolid Biosciences Inc. | $1.1B | — | $8.09M | -40.6% | -$85.98M | $159.39M | $20.16M | Fair valued |
| ENOVEnovis CORP | $1.11B | — | $2.25B | +6.7% | -$1.18B | $12.56M | $1.31B | Undervalued |
| BOWBowhead Specialty Holdings Inc. | $1.11B | 18.1× | $551.59M | +29.6% | $53.79M | $141.75M | $146.57M | Fair valued |
| CFFNCapitol Federal Financial, Inc. | $1.11B | 13.6× | $201.04M | +20.2% | $68.03M | $136.1M | $1.64B | Fair valued |
| ECVTEcovyst Inc. | $1.11B | — | $723.52M | +20.9% | -$71.13M | $87.76M | $546.35M | Fair valued |